IMMUNOMODULATORY ACTIVITIES OF SOME COMMON LICHEN METABOLITES

Authors

  • Vinitha M. Thadhani Sri Lankan Institute of Nanotechnology, Mahenwatta, Pitipana, Homagama, Sri Lanka
  • M. Ahmed Mesaik University of Karachi
  • Muhammad Asif University of Karachi,
  • Veranja Karunaratne Sri Lankan Institute of Nanotechnology, Mahenwatta, Pitipana, Homagama
  • Iqbal M. Choudhary University of Karachi

Keywords:

Lichen compounds, Immunomodulatory activities, Lobaric acid, Lecanoric acid, Orsellinic acid, Methyl haematomate, Methyl orsellinate, lumino- or lucigenin based chemiluminescence assay

Abstract

Objective: To evaluate the immunomodulatory activities of some of the common lichen compounds by using chemiluminescence based cellular assays.

Methods: Number of secondary lichen metabolites, representing a breadth of lichen substances, were investigated for their effects on the respiratory burst of human whole blood phagocytes, isolated human polymorphonuclear leukocytes (PMNs) and murine macrophages using luminol or lucigenin-based chemiluminescence probes.

Results: This study identify a clear suppressive effect of some lichen metabolites on phagocytosis response upon activation with serum opsonized zymosan by several lichen substances. Amongst the compounds tested, orsellinic acid, methyl orsellinate, methyl haematomate, lecanoric acid and lobaric acid, showed a potent immunomodulatory activity as compared to the standards. The lobaric acid suppressed both the myloperoxidase dependent and myloperoxidase independent, Reactive Oxygen Species (ROS) production in the oxidative burst of polymorphonuclear neutrophils (PMN) at the lowest concentration tested (3.1 µg/ml). Whereas, lecanoric acid, suppressed only the myloperoxidase dependent ROS production with IC50< 3.1µg/ml when compared to the standard sodium diethyldithiocarbamate trihydrate (SDT) (IC50 = 1.3 ± 0.2 µg/ml). Orsellinic acid, methyl orsellinate and methyl haematomate showed a selective myloperoxidase independent pathway with IC50 values; < 3.1µg/ml; 6.1 ± 1.0 µg/ml;  3.3 ± 0.1 µg/ml, respectively, being lower as compared to standard SDT (IC50 = 8.2 ± 1.9 µg/ml).

Conclusion: Based on the results obtained it is appropriate to conclude that lichen are not only a good source of antioxidants, but also potent immunomodulators, and thus deserve to be investigated further.

 

Downloads

Download data is not yet available.

References

Utoh-Nedosa AU, Akah PA, Okoye TC, Okoli CO. Evaluation of the toxic effects of dihydro artemisinin on the vital organs of Wistar albino rats. Am J Pharmacol Toxicol 2009;4:169-73.

Tzianabos O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 2000;13:523-33.

Herrmann ML, Schleyerbach R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immuno pharmacology 2000;47:273–89.

Hongyi S, Shaofei W, Shuhong Li, Xi Yuan, Jian Ma, Zhenya Z. Antioxidant activity and immunomodulatory of extracts from roots of Actinidia kolomikta. Int J Biol 2013;5:1.

Sayed H, Ashry EI, Amer MR, Abdalla OM, Aly AA, Samreen S, et al. Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-Oxo-cyclohex-1-ENE]carbodithioates, as potential immune-modulatory and immunosuppressive agents. Bioorg Med Chem 2012;20:3000-8.

Labadie RP. Immunomodulatory compounds. In: Steven M, Russel JM. Eds. Bioactive Natural Products: Detection, Isolation, and Structure Determination. CRC Press: London; 1993. p. 279-31.

Orange A, Wolseley P, Karunaratne V, Bombuwela K. Two leprarioid lichens new to Sri Lanka. Bibl Lichenol 2001;78:327-33.

Jayalal RGU, Wolseley PA, Gueidan C, Aptroot A, Wijesundara DSA, Karunaratne V. Anzia mahaeliyensis and Anzia flavotenuis, two new species from Sri Lanka. Lichenologist 2012;44:381-9.

Kathirgamanathar S, Ratnasooriya WD, Baekstrom P, Andersen RJ, Karunaratne V. Chemistry and bioactivity of physciaceae lichens Pyxine consocians and Heterodermia leucomelos. Pharm Biol 2006;44:217-20.

Vasudeo PZ, Lew PC. Biopharmaceutical potential of lichens. Pharm Biol 2012;50:778–98.

Thadhani VM, Choudhary MI, Ali S, Omar I, Siddique H, Karunaratne V. Antioxidant activity of some lichen metabolites. Nat Prod Res 2011;25:1827-37.

Choudhary MI, Ali S, Thadhani VM, Karunaratne V. Natural novel antioxidants, patent application: US 20090048332; 2009.

Pollyanna ASW, Rita CMO, Aldeidia PO, Mairim RS, Adriano ASA, Daniel PG, et al. Antioxidant activity and mechanisms of action of natural compounds isolated from lichens: a systematic review. Molecules 2014;19:14496-527.

Thadhani VM, Naaz Q, Choudhary MI, Mesaik MA, Karunaratne V. Enzyme inhibitory and immunomodulatory activities of the depsidone lobaric acid extracted from the lichen Heterodermia sp. J Natn Sci Found Sri Lanka 2014;42:193-6.

Mesaik MA, Jabeen A, Halim SA, Begum A, Khalid AS, Asif M, et al. In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa. Chem Biol Drug Des 2012;79:290-9.

Helfand SL, Werkmeister J, Roder JC. Chemiluminescence response of human natural killer cells. The relationship between target cell binding, chemiluminescence and cytolysis. J Exp Med 1982;156:492-505.

Published

01-11-2015

How to Cite

Thadhani, V. M., M. A. Mesaik, M. Asif, V. Karunaratne, and I. M. Choudhary. “IMMUNOMODULATORY ACTIVITIES OF SOME COMMON LICHEN METABOLITES”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 11, Nov. 2015, pp. 144-7, https://innovareacademics.in/journals/index.php/ijpps/article/view/7984.

Issue

Section

Original Article(s)